Cleanroom Industry News Articles

ASGARD Partners & Co. Acquires Angstrom Technology

ASGARD Partners & Co., a New York-based private equity firm, today announced an agreement to acquire a controlling interest in Angstrom Technology

Prime Minister announces £20m to grow medicines manufacturing in the UK

The Prime Minister will launch the government’s new capital investment fund, the Medicines and Diagnostic Manufacturing Transformation Fund, while visiting North Wales later today. This will open up investment opportunities for medicines manufacturers in England, Scotland and Wales – improving our domestic medicine supply chains and creating thousands of highly skilled jobs in the process.

NoviSphere™ Launches Pathogen-Eradication System

NoviSphere™, a developer of comprehensive rarified-environment solutions officially launched today. Using scientifically proven short-wavelength ultraviolet (UV-C) pathogen-eradication systems and additional cleanroom technologies, NoviSphere delivers ultraclean, protected environments that promote health and safety, allowing people to get back to business, back to work and back to life.

Essentium Introduces Industry-First Anti-Static Material To Advance Additive Manufacturing Applications In The Aerospace And Defense Industries

Summa Equity acquires G-CON Manufacturing, the leading US-based provider of POD® cleanroom solutions

Summa Equity Fund II (“Summa”) has acquired a majority stake in G-CON, a leading US-based manufacturer of prefabricated cleanrooms used for manufacturing within the pharmaceuticals industry. G-CON designs, builds and installs turnkey cGMP (Current Good Manufacturing Practice) compliant suites called PODs, for a global biopharma customer base focused on biologics, pharma, CDMO (contract development and manufacturing), and cell and gene therapy manufacturing.

GlobalFoundries Plans to Build New Fab in Upstate New York in Private-Public Partnership to Support U.S. Semiconductor Manufacturing

GlobalFoundries (GF), the global leader in feature-rich semiconductor manufacturing, today announced its expansion plans for its most advanced manufacturing facility in upstate New York over the coming years. These plans include immediate investments to address the global chip shortage at its existing Fab 8 facility as well as construction of a new fab on the same campus that will double the site’s capacity.

Freudenberg Medical Supports the Fight against Covid-19 in India

Freudenberg Medical, part of the Freudenberg Group and a global contract manufacturing partner to the medical device and pharmaceutical industry, has added a support team in India for customer sales and service to the region. Freudenberg is committed to serving medical device and pharmaceutical customers also present in Asia Pacific region with local operations in China and Singapore.

ExoMars 2020 Rover Undergoes Cleaning in Ultra-Cleanroom Environment

ExoMars 2020 rover being pre-cleaned in an ultra-cleanroom environment in preparation for its sterilisation process, in an effort to prevent terrestrial microbes coming along for the ride to the red planet. Part of the Agency’s Life, Physical Sciences and Life Support Laboratory based in its Netherlands technical centre, This 35 sq. m ‘ISO Class 1’ cleanroom is one of the cleanest places in Europe.

Vertex Pharmaceuticals Acquires CTP-656 from Concert Pharmaceuticals for the Treatment of Cystic Fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has signed a definitive asset purchase agreement to acquire CTP-656 from Concert Pharmaceuticals (Nasdaq: CNCE). CTP-656 is an investigational cystic fibrosis transmembrane conductance regulator (CFTR) potentiator that has the potential to be used as part of future once-daily combination regimens of CFTR modulators that treat the underlying cause of cystic fibrosis (CF). As part of the agreement, Vertex will pay Concert $160 million in cash for all worldwide development and commercialization rights to CTP-656.

Cystic Fibrosis Therapy Improved by Lipid-Based Nanoparticles

Researchers at Oregon State University and Oregon Health & Science University are working on a treatment that holds great promise for improving the lives of cystic fibrosis patients. Cystic fibrosis is a progressive genetic disorder that results in persistent lung infection and afflicts 30,000 people in the U.S., with about 1,000 new cases diagnosed every year.

Clean Room Facility Brings 8-Inch Fabrication Capability to Cardiff University

Local business leaders across South Wales attended the launch of the new facility, which offers a range of solutions for companies working to develop 21st century technologies. Guests were able to learn more about the refurbished 225 square metre Clean Room facility and the role it plays in assisting businesses across South Wales as part of CS Connected – the world’s first Compound Semiconductor cluster.

Algae Outbreaks Increased by Nanomaterials

The last 10 years have seen a surge in the use of tiny substances called nanomaterials in agrochemicals like pesticides and fungicides. The idea is to provide more disease protection and better yields for crops, while decreasing the amount of toxins sprayed on agricultural fields.

Research team discovers drug compound that stop cancer cells from spreading

Research team discovers drug compound that stops cancer cells from spreading Via a mouse model, OHSU...

Low Cost Solar Cells for Mass Production

An international team of university researchers today reports solving a major fabrication challenge for perovskite cells — the intriguing potential challengers to silicon-based solar cells. These crystalline structures show great promise because they can absorb almost all wavelengths of light. Perovskite solar cells are already commercialized on a small scale, but recent vast improvements in their power conversion efficiency (PCE) are driving interest in using them as low-cost alternatives for solar panels.

Closing the gap: On the road to terahertz electronics

A team headed by the TUM physicists Alexander Holleitner and Reinhard Kienberger has succeeded for the first time in generating ultrashort electric pulses on a chip using metal antennas only a few nanometers in size, then running the signals a few millimeters above the surface and reading them in again a controlled manner. The technology enables the development of new, powerful terahertz components.

HPAPI Facility launches for production of the highest class of HPAPI

Minakem’s HPAPI production will be carried out with an Occupational Exposure Limit (OEL) below 0,1μg/m3/8h. This emphasis on Environment, Health and Safety (EHS) reflects Minakem’s more than 20 years’ experience in continuously monitoring and controlling hazardous working environments, marking its leadership in this area.

« Older Entries

Next Entries »